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Purpose or Objective: Treatment planning for volumetric 
modulated arc therapy (VMAT) is complex, as the result is 
highly dependent on the selected optimization objectives. 
The Auto-Planning module in Pinnacle³ 9.10 (Philips 
Healthcare, Fitchburg, WI, USA) aims at offering efficient 
automated planning that directly uses clinical goals for 
iterative optimization, pushes beyond these goals if possible, 
and delivers consistent plan quality. In this study, we 
compared the performance of two Auto-Planning techniques 
with our original clinical approach of manually optimized 
prostate cancer VMAT plans. 
 
Material and Methods: Techniques were evaluated for 23 
prostate cancer patients (all treated using a rectal balloon), 
18 of which underwent primary irradiation with a prescription 
dose (PD) of 70 Gy in 28 fractions. PTV (planning target 
volume) for these cases ranged from prostate only to 
prostate plus entire seminal vesicles. Five patients received 
salvage treatment with 65 Gy in 26 fractions.  
Two Auto-Planning techniques (AP1, AP2) were compared 
with the manually optimized clinical plan (MP) to evaluate 
plan quality, focusing on PTV coverage and OAR (organ at 
risk) sparing. AP1 contained clinical goals for rectal wall, anal 
wall, bladder and femoral heads (dose-volume relationship 
and mean dose goals). AP2 used the same technique, 
excluding the femoral heads, in order to focus on bladder, 
rectal and anal wall (which are more prone to toxicity), and 
including a goal to minimize dose on tissue outside PTV and 
OARs.  
Monitor units (MUs) for all plans were scaled to achieve a 
V95% ≥ 99% for the PTV. One 10 MV VMAT arc (95 to 265° 
counterclockwise) and two portal imaging beams (for online 
position verification, 5 MU each) were used.  
 
Results: Table 1 presents the results of the comparison. Both 
AP techniques show a significant increase in PTV mean dose 
and number of MU when compared to MP, while PTV max 
dose is not significantly different. With respect to OARs, 
Auto-Planning significantly spares all considered structures. 
AP2 indeed sacrifices sparing of femoral heads for more 
sparing of bladder, rectal and anal wall. See Figure 1 for an 
example of dose distributions and DVHs (dose volume 
histograms).  
We selected AP2 as our Auto-Planning technique for clinical 
use. For 10 subsequently treated patients, AP2 resulted in an 
approved plan on the first Auto-Planning run for all 8 patients 
undergoing primary irradiation. The 2 salvage patients 
needed extra goals for the femoral heads. 
Delta-4 measurements for 20 patients treated with AP2 
showed a mean gamma pass rate of 98.4 ± 1.4 %, while EBT3 
film QA on a subset of 10 patients resulted in a mean gamma 
pass rate of 97.4 ± 1.2 % (evaluated for 3%/3mm). 
 
Conclusion: Besides its efficiency and consistency, Auto-
Planning offers similar PTV coverage as the original clinical 
plans, combined with better sparing of bladder, rectal and 
anal wall. Thus, the module widens the therapeutic window 
and is now used as our clinical standard for prostate cancer 
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Purpose or Objective: The modulated arc (mARC) technique 
is Siemens analogue to volumetric modulated arc therapy 
(VMAT), with a different underlying principle and technical 
implementation. While this presents the only available 
rotational technique for existing Siemens users, only few 
treatment planning systems (TPS) are capable of mARC 
planning. In particular, the widespread Philips Pinnacle TPS 
does not support mARC. The purpose of this work is to 
present two solutions for mARC plan creation starting from 
either IMRT or SmartArc plans. 
 
Material and Methods: In the first approach, the user creates 
a step-and-shoot IMRT plan with any number of beams 
ordered either clockwise or counter-clockwise, and one 
segment per beam. If desired, a few beams with more than 
one segment can be included. This plan is then exported as 
RT-Dose and an in-house software is used to modify the file in 
such a way that it is interpreted by the linac as an mARC 
plan. For this aim, each single-segment beam is converted 
into an arclet of a user-specified length (usually 4°). The 
calculated dose distribution of the IMRT plan corresponds to 
the mARC treatment, because mARC dose is usually 
